AVXL vs NOAH Comparison

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Noah Holdings Ltd is a wealth management service provider. It focuses on wealth investment and asset allocation services for high-net-worth individuals and enterprises in China. The company operates through three segments: wealth management, asset management, and other business. Its product offerings consisting of over-the-counter wealth management and OTC asset management products and mutual fund products. The portfolio of the group mostly includes fixed income products, private equity funds and securities investment funds. Majority of the firm revenue is generated through one-time commissions and recurring service fees paid by third-party product providers.